What are the characteristics of unstable coronary lesions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Unstable Coronary Lesion Characteristics

Unstable coronary lesions are characterized by eccentricity, irregular borders, ulceration, haziness, and filling defects indicative of intracoronary thrombus—these are the key angiographic markers of high-risk plaques that require urgent intervention. 1

Angiographic Features

The European Society of Cardiology guidelines explicitly define the culprit lesion characteristics that identify instability 1:

  • Eccentricity: Asymmetric plaque distribution within the vessel
  • Irregular borders: Ragged, non-smooth vessel contours
  • Ulceration: Crater-like defects in the plaque surface
  • Haziness: Cloudy appearance suggesting thrombus or plaque disruption
  • Filling defects: Areas within the lumen characteristic of intracoronary thrombus

Important caveat: Coronary angiography has good specificity but poor sensitivity for detecting thrombi compared to angioscopy 1. This means you may miss thrombus on angiography alone, but when you see these features, they reliably indicate instability.

Pathophysiologic Characteristics

The most recent ACC/AHA guidelines 2, 3 emphasize that unstable lesions result from atherosclerotic plaque disruption (rupture or erosion) with associated partial or complete coronary thrombosis. The underlying pathology involves:

  • Plaque rupture or erosion: Disruption of the fibrous cap
  • Lipid-rich core: High lipid content increases instability 4
  • Thin fibrous cap: Approximately 70 μm thick (below current imaging resolution) 4
  • Inflammatory infiltration: Increased macrophages and T lymphocytes 5

Advanced Imaging Characteristics

When intravascular imaging is available, unstable lesions demonstrate 6:

  • Positive remodeling: Larger remodeling index (independent predictor of instability)
  • Low radiographic density on CT: <30 Hounsfield Units (independent predictor of instability)
  • Reduced calcification: Lower degree of calcium content
  • Soft plaque composition: Higher prevalence of lipid-rich, poorly echo-reflective tissue

High-risk plaque features on coronary CTA include 7:

  • Spotty calcifications
  • Low attenuation plaque (<30 HU)
  • Positive remodeling
  • "Napkin-ring sign"

When two or more of these features are present, the lesion should be classified as high-risk plaque (HRP).

Clinical Correlation

Research demonstrates that angioscopy shows plaque rupture and thrombosis in 68% of unstable angina patients versus only 17% of stable angina patients 8. However, standard angiography discriminates poorly between stable and unstable lesions, with only 55% concordance between complex angiographic appearance and unstable angina 8.

The combination of unstable angina presentation AND complex lesion morphology is strongly associated with increased plaque inflammation 5, with macrophage content reaching 21% in unstable versus 13% in stable lesions.

Lesions That Preclude Intervention

Additional anatomic features that complicate management 1:

  • Extreme tortuosity: Prevents device delivery
  • Heavy calcification: Impedes stent deployment
  • Location in a bend: Increases procedural risk
  • Large thrombus burden: May require delayed intervention with aggressive anticoagulation first

Dynamic Nature

Critical point: The pathophysiology of ACS is dynamic 2, 3. Patients can rapidly progress from unstable angina to NSTEMI to STEMI during initial evaluation. A recent case report 9 demonstrated that symptom resolution does not guarantee lesion stability—a nonculprit lesion progressed to total occlusion within 5 days despite medical therapy, emphasizing that all unstable-appearing lesions warrant consideration for complete revascularization during emergency PCI.

References

Related Questions

What is the recommended clonazepam dose and administration route for sedation in a patient with acute coronary syndrome?
What oral dose of clonazepam should be used for sedation in an adult with acute coronary syndrome?
How can I determine whether percutaneous coronary intervention (PCI) is indicated?
In a hemodynamically stable patient with acute coronary syndrome presenting to the emergency department, what are the indications for initiating angiotensin‑converting enzyme inhibitors and eplerenone, and what are the recommended initial doses?
What is the recommended intravenous nitroglycerin dosing protocol for acute coronary syndrome?
In a 60-year-old woman with atrial fibrillation on bisoprolol (beta‑blocker) 2.5 mg daily and warfarin 4 mg, presenting with palpitations and persistent tachycardia despite IV atenolol, what is the appropriate next step for rapid rate control?
What is the recommended next treatment for a 55-year-old female, sober from alcohol for 3 months, with a history of hypermobile Ehlers‑Danlos syndrome, postural orthostatic tachycardia syndrome, and mast‑cell activation syndrome, who presents with panic attacks and depression after failing sertraline, gabapentin, and escitalopram?
What throat spray is safe to use for sore throat during pregnancy?
Is Difflam (benzydamine hydrochloride) throat spray safe to use during pregnancy?
What is the recommended dosing and administration protocol for rapid‑acting insulin (lispro, aspart, or glulisine) in an adult without renal or hepatic impairment?
Is chlorhexidine throat spray safe to use during pregnancy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.